Header Logo

Connection

Nell Lurain to Antiviral Agents

This is a "connection" page, showing publications Nell Lurain has written about Antiviral Agents.
Connection Strength

1.213
  1. Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev. 2010 Oct; 23(4):689-712.
    View in: PubMed
    Score: 0.340
  2. Ginkgolic acid inhibits fusion of enveloped viruses. Sci Rep. 2020 03 16; 10(1):4746.
    View in: PubMed
    Score: 0.164
  3. Convallatoxin-Induced Reduction of Methionine Import Effectively Inhibits Human Cytomegalovirus Infection and Replication. J Virol. 2016 Dec 01; 90(23):10715-10727.
    View in: PubMed
    Score: 0.130
  4. Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents. J Virol. 1992 Dec; 66(12):7146-52.
    View in: PubMed
    Score: 0.099
  5. Utility of leflunomide in the treatment of complex cytomegalovirus syndromes. Transplantation. 2010 Aug 27; 90(4):419-26.
    View in: PubMed
    Score: 0.085
  6. Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. J Infect Dis. 2003 Jul 01; 188(1):32-9.
    View in: PubMed
    Score: 0.051
  7. Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. J Infect Dis. 2003 Mar 01; 187(5):777-84.
    View in: PubMed
    Score: 0.050
  8. Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing. Antimicrob Agents Chemother. 2001 Oct; 45(10):2775-80.
    View in: PubMed
    Score: 0.046
  9. Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. Antimicrob Agents Chemother. 1999 Jun; 43(6):1500-2.
    View in: PubMed
    Score: 0.039
  10. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology. 1999; 42(5-6):412-8.
    View in: PubMed
    Score: 0.038
  11. Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates. Antimicrob Agents Chemother. 1998 Sep; 42(9):2326-31.
    View in: PubMed
    Score: 0.037
  12. Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates. J Clin Microbiol. 1998 Apr; 36(4):958-64.
    View in: PubMed
    Score: 0.036
  13. Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients. Transpl Infect Dis. 2014 Dec; 16(6):941-50.
    View in: PubMed
    Score: 0.028
  14. In situ ELISA for the evaluation of antiviral compounds effective against human cytomegalovirus. J Virol Methods. 1991 Nov-Dec; 35(2):207-15.
    View in: PubMed
    Score: 0.023
  15. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis. 2008 May 01; 46(9):1455-7.
    View in: PubMed
    Score: 0.018
  16. Emergence and compartmentalization of fatal multi-drug-resistant cytomegalovirus infection in a patient with autosomal-recessive severe combined immune deficiency. J Pediatr Hematol Oncol. 2004 Sep; 26(9):601-5.
    View in: PubMed
    Score: 0.014
  17. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation. 1999 Sep 27; 68(6):814-25.
    View in: PubMed
    Score: 0.010
  18. A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors. J Infect Dis. 1992 Oct; 166(4):904-7.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.